| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/19/2006 | CN1759885A Composition of medication used for acute lung injury |
| 04/19/2006 | CN1759856A Compound preparation of multi-metalloidlothioneins and intrinsic biological active matter of earthworm |
| 04/19/2006 | CN1252257C Human G-type lysozyme and its coding sequence, preparing process and application |
| 04/19/2006 | CN1252254C Defibrase modified by carbowax |
| 04/19/2006 | CN1252089C Construction and preparation of stroma cell derivative factor ¿C 1alpha recombinant mutant |
| 04/19/2006 | CN1252088C Deer serum active polypeptide crystal preparation and its preparing method |
| 04/19/2006 | CN1252085C Peptide as VEGF receptor KDR antagonist |
| 04/19/2006 | CN1251761C Vaccine comprising cytokine-induced heat shock proteins |
| 04/19/2006 | CN1251760C Chaenomeles fruit element contained lozenge and its preparation |
| 04/19/2006 | CN1251759C Biological degradable injectable bracket of modified hydrogel for use in cartilage tissue engineering |
| 04/19/2006 | CN1251758C Use of derivatives of valproic acid and 2-valproenic acid amides for treatment of mania in bipolar disorder |
| 04/19/2006 | CN1251689C Veal-blood protein-removed extract infusion and its preparation process |
| 04/19/2006 | CN1251687C Medicinal composition for treationg virus infention of rlavivirus family, set group and packaged products |
| 04/19/2006 | CN1251663C Oil-in-water oxidation paste emulsion for treating human kexatin fiber |
| 04/18/2006 | USRE39071 Anhydro-and isomer-a-21978c cyclic peptides |
| 04/18/2006 | US7030296 Toxin gene from the bacteria photorhabdus luminescens |
| 04/18/2006 | US7030291 CYT28 serpentine receptor disruptions, compositions and methods relating thereto |
| 04/18/2006 | US7030265 Retinol derivatives, the method of preparations and the uses thereof |
| 04/18/2006 | US7030239 Compounds to treat Alzheimer's disease |
| 04/18/2006 | US7030238 C-nitroso compounds and use thereof |
| 04/18/2006 | US7030236 Antisense oligonucleotides tarageting folate receptor alpha, and the use thereof |
| 04/18/2006 | US7030235 Nucleic acid primer or probe in a kit, for diagnosing a hearing disorder due to gene defects; encoding a protein with an amino acid at target position residue; monoclonal antibody; gene therapy, biodrugs |
| 04/18/2006 | US7030232 E25A protein, methods for producing and use thereof |
| 04/18/2006 | US7030227 Cell regulatory genes, encoded products, and uses related thereto |
| 04/18/2006 | US7030226 Fc fusion proteins of human erythropoietin with increased biological activities |
| 04/18/2006 | US7030225 Antibodies to JTT-1 protein, cells secreting such antibodies, and methods of making such antibodies |
| 04/18/2006 | US7030224 Human cytoplasmic polyadenylation element binding protein and uses thereof |
| 04/18/2006 | US7030223 Novel protein factors which share homologous sequences and biological activities with megakaryocyte colony-stimulating factor (meg-CSF); genetic engineering |
| 04/18/2006 | US7030222 Human gastric cancer antigen gene and gastric cancer antigen protein |
| 04/18/2006 | US7030219 Nucleotide sequences coding protein for use in treatment of cancer and prevention of viral infection |
| 04/18/2006 | US7030218 Extending ligation technique to peptides, polypeptides, other polymers and other molecules via an amide bond; used in the synthesis of optionally polymer-modified, synthetic bioactive proteins, and of pharmaceutical compositions |
| 04/18/2006 | US7030215 Position dependent recognition of GNN nucleotide triplets by zinc fingers |
| 04/18/2006 | US7030214 Ureins derived from α, ω, diamino acids and process for their preparation |
| 04/18/2006 | US7030213 Conformationally stabilized cell adhesion peptides |
| 04/18/2006 | US7030212 Tumor antigen based on products of the tumor suppressor gene WT1 |
| 04/18/2006 | US7030211 Antigenic peptides derived from telomerase |
| 04/18/2006 | US7030210 Use of ligand binding domain as a diagnostic tool in detection of preferential biopolymers in sample |
| 04/18/2006 | US7030133 Inhibitors of formation of advanced glycation endproducts (AGEs) |
| 04/18/2006 | US7030106 Ezetimibe formulation with lactose, croscarmellose sodium, povidone, sodium lauryl sulfate, magnesium stearate and microcrystalline cellulose |
| 04/18/2006 | US7030096 transduction of DNA sequences by naked DNA transfer, expression of genes that code for muscle tone controllers; gene therapy for prophylaxis of erectile dysfunction, urogenital and muscular disorders |
| 04/18/2006 | US7030091 Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin |
| 04/18/2006 | US7030090 Immune-modulating peptide |
| 04/18/2006 | US7030088 Human secreted hemopexin-related proteins |
| 04/18/2006 | US7030087 A water-soluble polypeptide having hydrophobic side chains, for use as bactericides treating infections, detoxification of endotoxin, cell antiproliferative agents, antagonist of tumor necrosis factor |
| 04/18/2006 | US7030086 Stabilized liquid polypeptide-containing pharmaceutical compositions |
| 04/18/2006 | US7030085 Thiopeptide compounds |
| 04/18/2006 | US7030084 Drug-oligomer conjugates with polyethylene glycol components |
| 04/18/2006 | US7030083 Prevention and treatment of endothelial injury and the injury of tissues containing injured blood vessels by administration of vascular endothelial cell growth factor |
| 04/18/2006 | US7030082 Administering mixtures of calcitonin conjugated to poplyethylene glycol, bile acids and carriers, for prophylaxis of bone disorders |
| 04/18/2006 | US7030081 Muteins of the Ser-Cys-Asn-Thr-Ala-Thr-Cys sequence from the N- terminal 1-7 fragment of the CGRP (calcitonin gene related peptide), activates neuronal nicotinic receptor, therefor useful for therapy of neurological disorders |
| 04/18/2006 | US7030080 Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof |
| 04/18/2006 | US7029914 DNA encoding SNORF36 receptors |
| 04/18/2006 | US7029906 For reducing carbonyl stress in peritoneal dialysate |
| 04/18/2006 | US7029901 Peptide for use in the treatment of inflammation, cancer and arteriosclerosis |
| 04/18/2006 | US7029899 Selective toxicity of amino-terminal modified rnase a superfamily polypeptides |
| 04/18/2006 | US7029898 Comprises chimeric polypeptide with hydrolase and mitogen activated protein kinase activity for diagnosis and treatment of cell proliferation and differentiation disorders |
| 04/18/2006 | US7029895 Comprises nucleotide sequences coding cardiolipin for diagnosis and treatment of lung, heart and respiratory disorders |
| 04/18/2006 | US7029892 nucleic acids coding this enzyme; genetic engineering; isolated polpeptide; insertion vector |
| 04/18/2006 | US7029878 Melanin concentrating hormone receptor chimeric and fusion proteins |
| 04/18/2006 | US7029877 binding protease thrombin to phosphoethanolamine binding protein |
| 04/18/2006 | US7029872 Methods for producing modified glycoproteins |
| 04/18/2006 | US7029871 Polypeptide for use in screening chemical libraries for lead compounds and for use in human therapeutics |
| 04/18/2006 | US7029862 Method for identifying ligands, inhibitors or promoters of CXC chemokine receptor 3 |
| 04/18/2006 | US7029860 Amyloid-β protein aggregation-regulating factors |
| 04/18/2006 | US7029859 Sequences for targeting metastatic cells |
| 04/18/2006 | US7029858 Genetic engineering; binding collagen to integrins; vaccine |
| 04/18/2006 | US7029857 Isolated nucleic acids; competitive binding |
| 04/18/2006 | US7029713 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising the same |
| 04/18/2006 | US7029695 Therapeutic compositions containing glutathione analogs |
| 04/18/2006 | US7029686 Variants of Phleum pratense allergenic proteins |
| 04/18/2006 | US7029680 Delivery of immunogenic molecules vis HBsAg particles |
| 04/18/2006 | US7029677 Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells |
| 04/18/2006 | US7029676 Peptide composition for us e in the treatment of psoriasis |
| 04/18/2006 | US7029674 contacting an immune cell with an agent that modulates the interaction between PD-1 and a PD-1 ligand (e.g., soluble forms of PD-1 or PD-1 ligand or antibodies to PD-1); inhibits signaling via PD-1 |
| 04/18/2006 | US7029673 Regulatory protein for Nox enzymes |
| 04/18/2006 | US7029672 Use of quinone Q10 for the treatment of ocular diseases |
| 04/18/2006 | US7029664 Chicken leukemia inhibitory factor (LIF) |
| 04/18/2006 | US7029652 Administering dose of antiangiogenic cyclo-arginine-glycine-aspartic acid- containing pentapeptide (cRGD pentapeptide), radioimmunotherapeutic agent (RIT), and one additional dose of cRGD pentapeptide |
| 04/18/2006 | US7028686 Inhaled insulin dosage control delivery enhanced by controlling total inhaled volume |
| 04/18/2006 | CA2268825C Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
| 04/18/2006 | CA2252505C New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
| 04/18/2006 | CA2089446C Composition for stabilizing blood plasma during pasteurization and pasteurized plasmic solution, for therapeutic purposes |
| 04/13/2006 | WO2006039668A2 3-ether and 3-thioether substituted cyclosporin derivatives for the treatment and prevention of hepatitis c infection |
| 04/13/2006 | WO2006039652A2 Chondroitin sulfate a binding domains |
| 04/13/2006 | WO2006039604A1 Use of pregnancy specific glycoprotein for maturation of oocytes |
| 04/13/2006 | WO2006039592A1 Use of il-17- for maturation of oocytes |
| 04/13/2006 | WO2006039527A1 Macrocyclic sh2 domain binding inhibitors |
| 04/13/2006 | WO2006039488A2 Hcv ns3-ns4a protease inhibition |
| 04/13/2006 | WO2006039407A2 Validation of tssk family members and tsks as male contraceptive targets |
| 04/13/2006 | WO2006039400A2 Fsh and fsh receptor modulator compositions and methods for inhibiting osteoclastic bone resorption and bone loss in osteoporosis |
| 04/13/2006 | WO2006039326A2 Inhibitors of hepatitits c virus |
| 04/13/2006 | WO2006039256A1 Use of gpr103 agonists for modulating feeding behaviour |
| 04/13/2006 | WO2006039164A2 Novel cyclosporin analogues and their pharmaceutical uses |
| 04/13/2006 | WO2006039163A2 Cyclosporin alkyne analogues and their pharmaceutical uses |
| 04/13/2006 | WO2006039073A2 Methods and compositions for reducing a level of a toxic protein in a cell |
| 04/13/2006 | WO2006039014A1 Cosmetic neurotoxin compositions comprising a botulinum toxin component and methods |
| 04/13/2006 | WO2006038880A1 New composition and method |
| 04/13/2006 | WO2006038729A1 Mutated amyloid protein |
| 04/13/2006 | WO2006038208A2 Agents capable of downregulating an msf-a - dependent hif-1α and use thereof in cancer treatment |
| 04/13/2006 | WO2006038088A1 Use of [d-meala]3-[etval]4-cyclosporin for the treatment of hepatitis c infection and pharmaceutical composition comprising said [d-meala]3-[etval]4-cyclosporin |